ClinicalTrials.gg
RecruitingNCT07209254SMART BPUpdated May 22, 2026

Randomized Controlled Trial of Two Mobile Health Strategies to Manage Postpartum Hypertension

An interventional study of High-touch blood pressure management and Low-touch blood pressure management in Hypertension, Pregnancy Induced, sponsored by Jennifer Lewey, MD, MPH. Recruiting at 3 sites in United States. Open to female participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-05-22.

Sponsored by Jennifer Lewey, MD, MPH · Not applicable, Interventional, and Treatment

How we know

From the registry’s dates

  • Started Mar 2026; still recruiting 8 months later.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
770
Allocation
Randomized
Ages
18 Years and older
Sex
Female
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 106 studies in Hypertension, Pregnancy-Induced with a site in United States — 30 open to participants now, 40 under way, 4 of them phase 3. Hypertension, Pregnancy-Induced · United States.

Planned enrollment
9th of 89
770 · median 120
Started
2026
with 8 others
No phase
51 of 106
14 open now
Primary completion
2029-10
later than 38 of 39 live
Registered
100th of 106
by date

Among the 106 studies in Hypertension, Pregnancy-Induced with a site in United States, this one is the 9th largest by planned enrollment of the 89 interventional ones that give a count, is one of 9 that started in 2026, is one of 51 with no phase, reaches primary completion later than 38 of the 39 other live ones, and was the 100th registered.

Hypertension, Pregnancy-Induced

262 studies on the registry are indexed under Hypertension, Pregnancy-Induced; 70 are open to participants now.

Browse Hypertension, Pregnancy-Induced studies →

Open to participants now

30 of the 106 studies in Hypertension, Pregnancy-Induced with a site in United States are open now. Recruiting first, the newest first:

24 more — sign in →

All 30 open studies →

A study can be open while its sites in United States have not opened yet or have stopped. Only those recruiting at a site in United States →

Who these studies take

Of the 53 Hypertension, Pregnancy-Induced studies recruiting now, 23 (43%) set no upper age limit and 29 (55%) stop at 75 or younger; 7 take children under 18; 16 take healthy volunteers.

This study: 18 Years and older · female · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 106 studies in Hypertension, Pregnancy-Induced with a site in United States, or all of them as a file.
02

Study summary

A multicenter randomized trial that will compare the effectiveness of two postpartum blood pressure (BP) management strategies in improving blood pressure and cardiac function and increasing patient engagement and feeling of control over one's health

03

Conditions studied

  • Hypertension, Pregnancy Induced

Keywords

  • Postpartum Hypertension
  • Blood pressure management
  • Preeclampsia
  • Hypertension, pregnancy induced
04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
Female
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Age ≥18 years
  • Delivery within 14 days
  • Diagnosis of preeclampsia or gestational hypertension with or without severe features during pregnancy or within 14 days postpartum
  • Initiation of blood pressure medication prior to hospital discharge and up to 14 days postpartum
  • English or Spanish speaking (able to read/understand consent and instructions)
  • Has phone texting capabilities

Exclusion criteria

Exclusion Criteria:

  • Diagnosis of chronic hypertension prior to delivery (would therefore include super imposed preeclampsia)
  • Pre-existing cardiovascular disease (including prior myocardial infarction, stroke, heart failure with reduced , ventricular tachycardia, prior cardiac arrest, pacemaker, severe valvular heart disease, or prior cardiac surgery)
  • Chronic kidney disease (stage 3 or higher)
  • Using ≥3 BP medications at time of enrollment
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

LVEF (left ventricular ejection fraction)

The share of blood the heart’s main pumping chamber (the left ventricle) pushes out with each beat, measured by an echocardiogram (heart ultrasound) or a MUGA scan. About 50–70% is normal.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
770 participants (estimated)

Study arms

  • Experimental
    High-touch blood pressure management

    Other: High-touch blood pressure management

  • Experimental
    Low-touch blood pressure management

    Other: Low-touch blood pressure management

Interventions

  • OtherHigh-touch blood pressure management

    Twelve weeks of text-based home blood pressure monitoring with BP self-management and team-based care

  • OtherLow-touch blood pressure management

    10 days of text-based home blood pressure monitoring

06

What researchers measure

Primary outcomes

  1. Mean diastolic blood pressure (DBP)

    Assessed by 24-hour ambulatory blood pressure monitor (ABPM)

    Time frame: 12 months postpartum

Secondary outcomes

  1. Blood pressure outcome: Mean systolic blood pressure (SBP)

    Assessed by 24-hour ambulatory blood pressure monitor (ABPM)

    Time frame: 12 months postpartum

  2. Blood pressure outcome: Mean nocturnal DBP

    Assessed by ABPM

    Time frame: 12 months postpartum

  3. Blood pressure outcome: Mean nocturnal SBP

    Assessed by ABPM

    Time frame: 12 months postpartum

  4. Blood pressure outcome: Mean DBP

    Assessed by home blood pressure monitor and office measurement

    Time frame: 12 months postpartum

  5. Chronic Hypertension

    Defined as 24-hour mean systolic blood pressure greater than or equal to 12mmHg, mean diastolic blood pressure greater than or equal to 75mmHg as assessed by ABPM or taking BP medication

    Time frame: 12 months postpartum

  6. Echocardiogram Outcomes

    Patients will all undergo a routine transthoracic echocardiogram. Measurements include: Left ventricle (LV) mass index, Relative wall thickness, mean E/e' ratio, left atrial (LA) volume index, global longitudinal strain.

    Time frame: 12 months postpartum

  7. Patient Reported Outcome - Patient Activation Measure

    Patient Activation Measure (PAM) is a 10 survey that assesses an individual's knowledge, skills and confidence integral to managing one's own health and healthcare. Scored on a scale from 0-100 that correlates to one of four levels of patient activation. PAM Levels 1 and 2 indicate lower patient activation, while PAM Levels 3 and 4 indicate higher patient activation. Survey will be completed at 3 timepoints: at randomization, 6-10 weeks postpartum, and 12 months postpartum

    Time frame: Post-randomization to 1 year postpartum

  8. Patient Reported Outcome - Perceived Stress

    Scores from the validated Perceived Stress Scale (PSS-10) will be calculated using standard scoring criteria for each of the 10 items. Higher scores are correlated with more perceived stress. Survey to be completed at randomization, at 6-10 weeks postpartum, and at 1 year postpartum.

    Time frame: Post-randomization to 1 year postpartum

  9. Patient Reported Outcome - Self-Efficacy

    New General Self-Efficacy Scale is an 8-item measure that assesses how much people believe they can achieve their goals, despite difficulties. Using a 5-point rating scale where 1=strongly disagree and 5=strongly agree, scores are calculated by taking the average of their ratings. Survey to be completed at randomization, at 6-10 weeks postpartum, and at 1 year postpartum.

    Time frame: Post randomization to 1 year postpartum

  10. Implementation Outcome: Acceptability of Intervention

    Patients will be asked questions to assess the acceptability of the intervention. The questions will be scored on a Likert response scales from 1 to 5. Higher scores represent higher acceptability. Asked at two time points, 6 weeks and 12 months postpartum.

    Time frame: From 6 weeks postpartum through 1 year postpartum

07

Study locations

2 of 3 sites recruiting
08

References and documents

Individual participant data

Plan to share: Yes

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Mar 2026 (actual). Primary completion is estimated for Oct 2029, 43 months after the start.

Of 91 non-industry interventional studies with no phase under Hypertension, Pregnancy-Induced, half reached primary completion within 24 months of starting (the median), counting those still running; a quarter within 10 and three quarters within 34. This study's planned 43 months is above that.

Counting every sponsor, half of 92 studies reached it within 24 months; a quarter within 10 and three quarters within 34.

How these figures are worked out, and which studies are left out of them.

Registered
Sep 30, 2025
First posted
Oct 6, 2025
StartActual
Mar 2, 2026
Primary completionEst.
Oct 2029
CompletionEst.
Nov 2029
Last update
May 22, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on May 22, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07209254
Lead sponsor
Jennifer Lewey, MD, MPH
Collaborators
Patient-Centered Outcomes Research Institute
Responsible party
Jennifer Lewey, MD, MPH (Assistant Professor of Medicine (Cardiovascular Medicine), University of Pennsylvania) — Sponsor-investigator
First posted
Oct 6, 2025
Start date
Mar 2, 2026
Primary completion
Oct 2029 (estimated)
Completion
Nov 2029 (estimated)
Last update
May 22, 2026

Study contacts

Jennifer Lewey, MD, MPH
Contact
Jennifer.Lewey@pennmedicine.upenn.edu
215-662-7700
Alexis Giron, M.S
Contact
Alexis.Giron@Pennmedicine.upenn.edu
Jennifer Lewey, MD, MPH
principal investigator · University of Pennsylvania

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion